Eagle Genomics raises £1m from London Business Angels and other investors to support product development and marketing.

The Cambridge-based bioinformatics specialist has closed a £1m investment round backed by London Business Angels.
"Eagle Genomics which is now at scale up stage is commercialising an effective bioinformatics software solution that has the potential to improve the way in which new medicines and therapies are developed. This round of growth capital funding from existing and new angel investors leaves the company well positioned to accelerate its growth in this fast growing market."




